Domain finds unmet need in CF

Unmet need drives Domain's investment in Celtaxsys, its first in CF

Domain Associates has decided the best way to play the cystic fibrosis space is to find a molecule that can be combined with the ever-increasing number of cocktails emerging from Vertex Pharmaceuticals Inc. (NASDAQ:VRTX). To do so, Domain led a

Read the full 409 word article

How to gain access

Continue reading with a
two-week free trial.